When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CRSP - The Must-Know Nobel Prize-Winning Biotech Trend Of Gene Editas Medicine
CRISPR Therapeutics AG
EDIT has an exclusive patent on the Nobel Prize-winning CRISPR technology that has the potential to change the biotech industry fundamentally.
CRISPR is an affordable, clean and effective technology that puts human genes under scientists' full control.
If the FDA approves EDIT's leading drug, called EDIT101, investors should expect slow, gradual sales growth, combined with increasing acquisition prospects from larger biotechs.